Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Prizes
Spin-Offs
Activities
Media
Search by expertise, name or affiliation
Pathophysiologie und Androgendeprivationstherapie des kastrationsresistenten Prostatakarzinoms
Translated title of the contribution
:
Pathophysiology and therapy of castration-resistant prostate cancer
A. S. Merseburger
*
, M. A. Kuczyk, J. M. Wolff
*
Corresponding author for this work
Clinic of Urology
Hannover Medical School
8
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pathophysiology and therapy of castration-resistant prostate cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Castration Resistant Prostate Cancer
100%
Enzalutamide
50%
Androgen
50%
Endocrine Therapy
25%
Abiraterone
25%
Antitumor Activity
25%
Neoplasm
25%
Prostate Cancer
25%
Androgen Receptor
25%